Brief: Medexus Pharmaceuticals Announces 512% Increase In Revenue To $14.4 Mln For Q3 Fiscal 2019
Feb 25 (Reuters) - Medexus Pharmaceuticals Inc MDP.V :
* MEDEXUS PHARMACEUTICALS ANNOUNCES 512% INCREASE IN REVENUE
TO
$14.4 MILLION FOR THE THIRD QUARTER OF FISCAL 2019
* QTRLY GROSS PROFIT INCREASED 657% TO $8.9 MILLION COMPARED
TO
$1.2 MILLION FOR Q3 2018
* REVENUE INCREASED 512% TO $14.4 MILLION COMPARED TO $2.4
MILLION
FOR Q3 2018
Source text for Eikon: ID:nGNX76cnq4
Further company coverage: MDP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million